FIELD: medicine, particularly, production of soft medicinal form designed for treatment of various mycoses of skin. SUBSTANCE: pharmaceutical composition contains terbinaphine hydrochloride, base, conserving agent, antioxidant, emulsifier, lipophil component and solvent, and may additionally include keratolytic at preset content of components. The invention also describes the method of producing pharmaceutical composition possessing antimycotic activity. EFFECT: increased antibacterial and antiinframmatory properties. 13 cl, 1 dwg, 1 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
STABILISED PHARMACEUTICAL FORMULATION WITH ANTIMYCOTIC ACTION | 2011 |
|
RU2450807C1 |
SOLID MEDICINAL FORM OF TERBINAFINE HYDROCHLORIDE | 2001 |
|
RU2200003C1 |
AGENT POSSESSING ANTIFUNGAL EFFECT AND METHOD FOR ITS PREPARING | 2005 |
|
RU2314800C2 |
AGENT FOR SUPERFICIAL MYCOSES TREATMENT | 2007 |
|
RU2337689C1 |
PHARMACEUTICAL COMPOSITION SHOWING ANTIFUNGAL ACTIVITY AND A METHOD OF ITS PREPARING | 1997 |
|
RU2120305C1 |
OINTMENT SHOWING IRRITATING EFFECT ON NERVE ENDINGS | 1997 |
|
RU2143888C1 |
METHOD OF PHOTOSENSIBILIZING AGENT PREPARING | 1993 |
|
RU2072861C1 |
PHARMACEUTICAL COMPOSITION ELICITING ANTIBACTERIAL ACTIVITY | 2002 |
|
RU2205011C1 |
NYSTATIN OINTMENT BASED ON POLYMER SHOWING ANTIFUNGAL EFFECT | 2001 |
|
RU2189222C1 |
SUPPOSITORY EXHIBITING ANTIFUNGAL EFFECT (VARIANTS) | 1996 |
|
RU2139707C1 |
Authors
Dates
2002-10-10—Published
2001-11-08—Filed